Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Some studies have found that about half of people who start taking a GLP-1 drug for weight loss stop taking it within a year—for various reasons—and many people think they can stop taking anti-obesity ...

A single, half-hour session of moderate exercise is enough to confer an immediate mood-boosting effect, and now scientists ...

Altimmune, Inc. nears key MASH data for pemvidutide—learn investor risks, potential rewards, and what the upcoming results ...

Tired eyes, restless thoughts and books that finally make rest feel within reach. Calm guidance, steady pacing and ideas that ...

Nitrous oxide may ease depression within hours, according to trials. Learn how long effects last, safety findings, and ...

At the time of writing, the ASX tech stock is up 18% to $1.96. Investors have been scrambling to buy the respiratory imaging ...

Parkinson’s Disease (PD) remains the second most prevalent neurodegenerative disorder worldwide, yet it continues to evade a definitive disease-modifying ...

A 16-week trial found more weight loss among subjects on a low-fat vegan diet in comparison to a Mediterranean diet.

Stanford scientists have taken a striking step toward reimagining type 1 diabetes treatment, using a carefully calibrated ...

The right preparation for a good night’s sleep is valuable for not only your physical health but your mental well-being too.